Plante Moran Financial Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,450
| Closed | -$5.25K | – | 842 |
|
|
2025
Q1 | $5.25K | Buy |
4,450
+3,340
| +301% | +$3.94K | ﹤0.01% | 640 |
|
|
2024
Q4 | $2.03K | Hold |
1,110
| – | – | ﹤0.01% | 779 |
|
|
2024
Q3 | $1.89K | Hold |
1,110
| – | – | ﹤0.01% | 759 |
|
|
2024
Q2 | $1.52K | Hold |
1,110
| – | – | ﹤0.01% | 715 |
|
|
2024
Q1 | $4.16K | Hold |
1,110
| – | – | ﹤0.01% | 704 |
|
|
2023
Q4 | $10.9K | Hold |
1,110
| – | – | ﹤0.01% | 547 |
|
|
2023
Q3 | $9.27K | Hold |
1,110
| – | – | ﹤0.01% | 538 |
|
|
2023
Q2 | $14.8K | Hold |
1,110
| – | – | ﹤0.01% | 499 |
|
|
2023
Q1 | $12.9K | Hold |
1,110
| – | – | ﹤0.01% | 522 |
|
|
2022
Q4 | $9.08K | Hold |
1,110
| – | – | ﹤0.01% | 593 |
|
|
2022
Q3 | $6K | Buy |
+1,110
| New | +$6K | ﹤0.01% | 666 |
|